K B Laupland1, L W Svenson, D B Gregson, D L Church. 1. Department of Medicine, University of Calgary and Alberta Health Services, Calgary, AB, Canada. Kevin.laupland@calgaryhealthregion.ca
Abstract
PURPOSE: Although bloodstream infection is widely recognized as an important cause of acute morbidity and mortality, long-term mortality outcomes are less well defined. The objective of this study was to define the early (≤28 days) and late (>28 days) mortality and assess determinants of late death following community-onset bloodstream infection. METHODS: All adult residents of the Calgary Zone who had community-onset bloodstream infections during the period 1 January 2003 and 31 December 2007 were included. The mortality outcome was assessed through to 31 December 2008. RESULTS: A total of 4,553 cases were identified, of which 2,105 (46%) were healthcare-associated and 2,448 (54%) were community-acquired. The 28-day, 90-day, and 365-day all-cause case-fatality rates were 561/4,553 (12%), 780/4,553 (17%), and 1,131 (25%), respectively. Within the first 28 days, the median time to death was 4 (interquartile range [IQR] 1-12) days, with 158 (28%) and 212 (38%) of early (≤28-day) deaths occurring by days 1 and 2, respectively. Among survivors to 28 days (n = 3,992), 570 (14%) suffered late 1-year mortality (i.e., death occurred between 29 and 365 days postinception). The most common causes of death in this cohort as listed by the vital statistics data were malignancy in 220 (39%), cardiovascular in 135 (24%), and infection-related in 37 (7%). Older age, higher Charlson score, prolonged initial admission duration, and healthcare-associated and polymicrobial infections were independently associated with late 1-year mortality. CONCLUSIONS: Community-onset bloodstream infection is associated with major early and late mortality.
PURPOSE: Although bloodstream infection is widely recognized as an important cause of acute morbidity and mortality, long-term mortality outcomes are less well defined. The objective of this study was to define the early (≤28 days) and late (>28 days) mortality and assess determinants of late death following community-onset bloodstream infection. METHODS: All adult residents of the Calgary Zone who had community-onset bloodstream infections during the period 1 January 2003 and 31 December 2007 were included. The mortality outcome was assessed through to 31 December 2008. RESULTS: A total of 4,553 cases were identified, of which 2,105 (46%) were healthcare-associated and 2,448 (54%) were community-acquired. The 28-day, 90-day, and 365-day all-cause case-fatality rates were 561/4,553 (12%), 780/4,553 (17%), and 1,131 (25%), respectively. Within the first 28 days, the median time to death was 4 (interquartile range [IQR] 1-12) days, with 158 (28%) and 212 (38%) of early (≤28-day) deaths occurring by days 1 and 2, respectively. Among survivors to 28 days (n = 3,992), 570 (14%) suffered late 1-year mortality (i.e., death occurred between 29 and 365 days postinception). The most common causes of death in this cohort as listed by the vital statistics data were malignancy in 220 (39%), cardiovascular in 135 (24%), and infection-related in 37 (7%). Older age, higher Charlson score, prolonged initial admission duration, and healthcare-associated and polymicrobial infections were independently associated with late 1-year mortality. CONCLUSIONS: Community-onset bloodstream infection is associated with major early and late mortality.
Authors: G Fätkenheuer; M Preuss; B Salzberger; N Schmeisser; O A Cornely; H Wisplinghoff; H Seifert Journal: Eur J Clin Microbiol Infect Dis Date: 2004-02-25 Impact factor: 3.267
Authors: Jenine Leal; Daniel B Gregson; Terry Ross; Ward W Flemons; Deirdre L Church; Kevin B Laupland Journal: Infect Control Hosp Epidemiol Date: 2010-07 Impact factor: 3.254
Authors: Jennie Johnstone; Dean T Eurich; Jasjeet K Minhas; Thomas J Marrie; Sumit R Majumdar Journal: Clin Infect Dis Date: 2010-07-01 Impact factor: 9.079
Authors: Jose Bordon; Timothy Wiemken; Paula Peyrani; Maria Luz Paz; Martin Gnoni; Patricio Cabral; Maria del Carmen Venero; Julio Ramirez Journal: Chest Date: 2010-04-09 Impact factor: 9.410
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: Franz Ratzinger; Katharina Eichbichler; Michael Schuardt; Irene Tsirkinidou; Dieter Mitteregger; Helmuth Haslacher; Thomas Perkmann; Klaus G Schmetterer; Georg Doffner; Heinz Burgmann Journal: Infection Date: 2015-04-04 Impact factor: 3.553
Authors: Anna Rautanen; Matti Pirinen; Tara C Mills; Kirk A Rockett; Amy Strange; Anne W Ndungu; Vivek Naranbhai; James J Gilchrist; Céline Bellenguez; Colin Freeman; Gavin Band; Suzannah J Bumpstead; Sarah Edkins; Eleni Giannoulatou; Emma Gray; Serge Dronov; Sarah E Hunt; Cordelia Langford; Richard D Pearson; Zhan Su; Damjan Vukcevic; Alex W Macharia; Sophie Uyoga; Carolyne Ndila; Neema Mturi; Patricia Njuguna; Shebe Mohammed; James A Berkley; Isaiah Mwangi; Salim Mwarumba; Barnes S Kitsao; Brett S Lowe; Susan C Morpeth; Iqbal Khandwalla; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Audrey Duncanson; Janusz Jankowski; Hugh S Markus; Christopher G Mathew; Colin N A Palmer; Robert Plomin; Stephen J Sawcer; Richard C Trembath; Ananth C Viswanathan; Nicholas W Wood; Panos Deloukas; Leena Peltonen; Thomas N Williams; J Anthony G Scott; Stephen J Chapman; Peter Donnelly; Adrian V S Hill; Chris C A Spencer Journal: Am J Hum Genet Date: 2016-05-26 Impact factor: 11.025
Authors: Kim O Gradel; Ulrich S Jensen; Henrik C Schønheyder; Christian Østergaard; Jenny D Knudsen; Sonja Wehberg; Mette Søgaard Journal: BMC Infect Dis Date: 2017-02-06 Impact factor: 3.090
Authors: Emma J Hamilton; Natalie Martin; Ashley Makepeace; Brett A Sillars; Wendy A Davis; Timothy M E Davis Journal: PLoS One Date: 2013-03-25 Impact factor: 3.240
Authors: Michael Dalager-Pedersen; Kristoffer Koch; Reimar Wernich Thomsen; Henrik Carl Schønheyder; Henrik Nielsen Journal: BMJ Open Date: 2014-01-29 Impact factor: 2.692